NCT02003937

Brief Summary

Spinal muscular atrophy type III, (SMAIII) is a disease in the nerve cells in the spinal cord which leads to to progressive muscle weakness and atrophy. No effective treatment is available for SMA. We have previously shown that patients with muscular dystrophies improve oxidative capacity (VO2max), muscle strength and daily function by aerobic conditioning. Patients with SMAIII share many clinical features with these conditions, although the mechanism of muscle weakness is different. In this study, we investigated how patients with SMAIII respond to aerobic training. 6 patients and 9 healthy age- and sex-matched controls completed a 12 weeks training program. Subjects performed a total of 42 training session of 30 min on a stationary cycle ergometer at home. The work intensity was moderate and set to match a target heart rate. Training induced an increase without inducing muscle damage. However, training-induced fatigue was a major complaint in all patients, and caused one patient to drop out, increased the need for sleep in three patients and two had to modify the training program. The fatigue limits the use of this therapy. The training-induced fatigue, which is not encountered in muscle diseases, warrants investigations into alternative training methods to improve quality of life in patients with SMAIII.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

August 22, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 6, 2013

Completed
Last Updated

October 29, 2015

Status Verified

October 1, 2015

Enrollment Period

1 year

First QC Date

August 22, 2013

Last Update Submit

October 28, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in oxidative capacity with aerobic conditioning in SMAIII patients

    After 12 weeks of aerobic training

Secondary Outcomes (3)

  • Changes in maximal workload capacity with aerobic conditioning in SMAIII patients

    After 12 weeks of aerobic conditioning

  • Changes in isometric muscle strength with aerobic conditioning in SMAIII patients

    After 12 weeks of aerobic conditioning

  • Changes in daily function with aerobic conditioning in SMAIII patients

    After 12 weeks of aerobic training

Study Arms (1)

12 weeks of aerobic conditioning

EXPERIMENTAL

12 weeks of aerobic conditioning, a total 42 sessions of 30min exercise on a stationary cycle ergometer

Behavioral: Aerobic conditioning

Interventions

Subjects performed 12 weeks of aerobic training on a stationary cycle ergometer. Subjects compleeted a total of 42 training sessions of 30min. exercise at an individually adjusted moderate workload.

12 weeks of aerobic conditioning

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Genetically verified SMAIII

You may not qualify if:

  • other serious medical conditions that could confound the interpretation of results and
  • regular exercise more than one hour weekly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet, Neuromuscular Research Unit, 3342

Copenhagen E, 2100, Denmark

Location

MeSH Terms

Conditions

Muscular Atrophy, Spinal

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesNeuromuscular Diseases

Study Officials

  • Karen L Madsen, M.Sc

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.Sc

Study Record Dates

First Submitted

August 22, 2013

First Posted

December 6, 2013

Study Start

September 1, 2009

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

October 29, 2015

Record last verified: 2015-10

Locations